Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event

The spectrum of TKI-related adverse events (AEs) is variable. Pleural effusion (PE) is a frequent AE attributable to dasatinib treatment, while it is only rarely associated with nilotinib. The pathogenetic mechanism leading to PE during nilotinib therapy is still unknown and its management has not y...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquale, Raffaella, Bucelli, Cristina, Bellani, Valentina, Zappa, Manuela, Iurlo, Alessandra, Cattaneo, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513037/
https://www.ncbi.nlm.nih.gov/pubmed/36176390
http://dx.doi.org/10.3389/fonc.2022.1012268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513037/
https://www.ncbi.nlm.nih.gov/pubmed/36176390
http://dx.doi.org/10.3389/fonc.2022.1012268

Ejemplares similares